Johnson & Johnson(JNJ)
Drug Manufacturers - General · New Brunswick, NJ
$269.12+0.00 (+0.00%)
Delayed quote: Sep 8, 2026, 4:00 PM EDT
Drug Manufacturers - General · New Brunswick, NJ
Delayed quote: Sep 8, 2026, 4:00 PM EDT
The latest quarterly acquisitions is −$263.00 Million with a quarter-over-quarter change of -1006.90%. Acquisitions represent cash spent to acquire other businesses and show externally purchased growth activity.
Reported quarterly acquisitions; no daily interpolation.
−$263.00M
−$263.00 Million
-1006.90%
vs. $29.00M prior quarter
96
Quarters of data available
| Period | Acquisitions | QoQ Change | % Change |
|---|---|---|---|
| Quarter ended Jun 2026 | −$263.00M | −$292.00M | -1006.90% |
| Quarter ended Mar 2026 | $29.00M | +$3.11B | +100.94% |
| Quarter ended Dec 2025 | −$3.08B | −$3.08B | -308100.00% |
| Quarter ended Sep 2025 | −$1.00M | +$14.46B | +99.99% |
| Quarter ended Jun 2025 | −$14.46B | −$14.74B | -5282.08% |
| Quarter ended Mar 2025 | $279.00M | +$280.00M | +28000.00% |
| Quarter ended Dec 2024 | −$1.00M | +$337.00M | +99.70% |
| Quarter ended Sep 2024 | −$338.00M | +$12.29B | +97.32% |
| Quarter ended Jun 2024 | −$12.63B | −$11.03B | -689.07% |
| Quarter ended Mar 2024 | −$1.60B | −$1.72B | -1423.14% |
| Quarter ended Dec 2023 | $121.00M | +$0 | 0.00% |
| Quarter ended Oct 2023 | $121.00M | +$45.00M | +59.21% |
| Quarter ended Jul 2023 | $76.00M | +$36.00M | +90.00% |
| Quarter ended Apr 2023 | $40.00M | +$17.17B | +100.23% |
| Quarter ended Dec 2022 | −$17.13B | −$17.13B | -1713100.00% |
| Quarter ended Oct 2022 | $1.00M | +$272.00M | +100.37% |
| Quarter ended Jul 2022 | −$271.00M | −$19.00M | -7.54% |
| Quarter ended Apr 2022 | −$252.00M | −$192.00M | -320.00% |
| Quarter ended Dec 2021 | −$60.00M | −$72.00M | -600.00% |
| Quarter ended Oct 2021 | $12.00M | −$39.00M | -76.47% |
| Quarter ended Jul 2021 | $51.00M | −$552.00M | -91.54% |
| Quarter ended Apr 2021 | $603.00M | +$6.98B | +109.46% |
| Quarter ended Dec 2020 | −$6.37B | −$6.37B | N/A |
| Quarter ended Sep 2020 | $0 | +$10.00M | +100.00% |
| Quarter ended Jun 2020 | −$10.00M | +$929.00M | +98.94% |
| Quarter ended Mar 2020 | −$939.00M | −$691.00M | -278.63% |
| Quarter ended Dec 2019 | −$248.00M | −$32.00M | -14.81% |
| Quarter ended Sep 2019 | −$216.00M | +$3.45B | +94.10% |
| Quarter ended Jun 2019 | −$3.66B | −$1.98B | -117.65% |
| Quarter ended Mar 2019 | −$1.68B | −$1.68B | -84050.00% |
| Quarter ended Dec 2018 | −$2.00M | +$673.00M | +99.70% |
| Quarter ended Sep 2018 | −$675.00M | −$535.00M | -382.14% |
| Quarter ended Jul 2018 | −$140.00M | −$58.00M | -70.73% |
| Quarter ended Apr 2018 | −$82.00M | +$423.00M | +83.76% |
| Quarter ended Dec 2017 | −$505.00M | +$69.00M | +12.02% |
| Quarter ended Oct 2017 | −$574.00M | +$28.65B | +98.04% |
| Quarter ended Jul 2017 | −$29.22B | −$24.37B | -502.23% |
| Quarter ended Apr 2017 | −$4.85B | −$4.39B | -957.08% |
| Quarter ended Dec 2016 | −$459.00M | +$2.86B | +86.17% |
| Quarter ended Oct 2016 | −$3.32B | −$2.60B | -357.93% |
| Quarter ended Jul 2016 | −$725.00M | −$720.00M | -14400.00% |
| Quarter ended Apr 2016 | −$5.00M | +$716.00M | +99.31% |
| Quarter ended Dec 2015 | −$721.00M | −$721.00M | N/A |
| Quarter ended Sep 2015 | $0 | +$0 | N/A |
| Quarter ended Jun 2015 | $0 | +$233.00M | +100.00% |
| Quarter ended Mar 2015 | −$233.00M | +$1.60B | +87.32% |
| Quarter ended Dec 2014 | −$1.84B | −$1.55B | -531.62% |
| Quarter ended Sep 2014 | −$291.00M | −$291.00M | N/A |
| Quarter ended Jun 2014 | $0 | +$0 | N/A |
| Quarter ended Mar 2014 | $0 | +$16.00M | +100.00% |
| Quarter ended Dec 2013 | −$16.00M | +$629.00M | +97.52% |
| Quarter ended Sep 2013 | −$645.00M | −$639.00M | -10650.00% |
| Quarter ended Jun 2013 | −$6.00M | +$162.00M | +96.43% |
| Quarter ended Mar 2013 | −$168.00M | −$105.00M | -166.67% |
| Quarter ended Dec 2012 | −$63.00M | −$13.30B | -100.48% |
| Quarter ended Sep 2012 | $13.24B | +$30.89B | +174.95% |
| Quarter ended Jul 2012 | −$17.66B | −$18.02B | -5032.68% |
| Quarter ended Apr 2012 | $358.00M | +$686.00M | +209.15% |
| Quarter ended Dec 2011 | −$328.00M | +$92.00M | +21.90% |
| Quarter ended Oct 2011 | −$420.00M | −$442.00M | -2009.09% |
| Quarter ended Jul 2011 | $22.00M | +$2.07B | +101.07% |
| Quarter ended Apr 2011 | −$2.05B | −$2.57B | -491.03% |
| Quarter ended Dec 2010 | $524.00M | +$922.00M | +231.66% |
| Quarter ended Oct 2010 | −$398.00M | −$299.00M | -302.02% |
| Quarter ended Jul 2010 | −$99.00M | +$673.00M | +87.18% |
| Quarter ended Apr 2010 | −$772.00M | −$639.00M | -480.45% |
| Quarter ended Dec 2009 | −$133.00M | +$913.00M | +87.28% |
| Quarter ended Sep 2009 | −$1.05B | −$1.05B | N/A |
| Quarter ended Jun 2009 | $0 | +$1.29B | +100.00% |
| Quarter ended Mar 2009 | −$1.29B | −$477.00M | -58.60% |
| Quarter ended Dec 2008 | −$814.00M | −$460.00M | -129.94% |
| Quarter ended Sep 2008 | −$354.00M | −$316.00M | -831.58% |
| Quarter ended Jun 2008 | −$38.00M | −$30.00M | -375.00% |
| Quarter ended Mar 2008 | −$8.00M | +$2.00M | +20.00% |
| Quarter ended Dec 2007 | −$10.00M | +$0 | 0.00% |
| Quarter ended Sep 2007 | −$10.00M | −$10.00M | N/A |
| Quarter ended Jul 2007 | $0 | +$1.37B | +100.00% |
| Quarter ended Apr 2007 | −$1.37B | +$15.28B | +91.78% |
| Quarter ended Dec 2006 | −$16.65B | −$16.49B | -10369.18% |
| Quarter ended Oct 2006 | −$159.00M | +$248.00M | +60.93% |
| Quarter ended Jul 2006 | −$407.00M | +$404.00M | +49.82% |
| Quarter ended Apr 2006 | −$811.00M | −$571.00M | -237.92% |
| Quarter ended Dec 2005 | −$240.00M | −$186.00M | -344.44% |
| Quarter ended Oct 2005 | −$54.00M | +$639.00M | +92.21% |
| Quarter ended Jul 2005 | −$693.00M | −$770.00M | -1000.00% |
| Quarter ended Apr 2005 | $77.00M | +$327.00M | +130.80% |
| Quarter ended Dec 2004 | −$250.00M | −$220.00M | -733.33% |
| Quarter ended Sep 2004 | −$30.00M | +$86.00M | +74.14% |
| Quarter ended Jun 2004 | −$116.00M | −$165.00M | -336.73% |
| Quarter ended Mar 2004 | $49.00M | +$80.00M | +258.06% |
| Quarter ended Dec 2003 | −$31.00M | −$32.00M | -3200.00% |
| Quarter ended Sep 2003 | $1.00M | +$2.52B | +100.04% |
| Quarter ended Jun 2003 | −$2.52B | −$2.27B | -877.91% |
| Quarter ended Mar 2003 | −$258.00M | −$246.00M | -2050.00% |
| Quarter ended Dec 2002 | −$12.00M | −$23.00M | -209.09% |
| Quarter ended Sep 2002 | $11.00M | N/A | N/A |